Literature DB >> 4124206

Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents.

M T Kelly, A White.   

Abstract

The role of cyclic AMP in histamine release induced by human leukocyte lysates was investigated. Leukocytes were incubated with leukocyte lysates prepared by ultrasonic disruption, and histamine was determined fluorimetrically. Several cyclic AMP-active agents had a marked inhibitory effect on histamine release. Theophylline and isoproterenol produced 50% inhibition at concentrations of less than 10(-5) M. Prostaglandin E(1) and dibutyryl cyclic AMP inhibited release by 50% at 7 x 10(-8) M and 6 x 10(-5) M concentrations, respectively. Histamine, which has recently been shown to increase leukocyte cyclic AMP, had a pronounced inhibitory effect on lysate-induced histamine release, producing 50% inhibition at a concentration of only 2.5 x 10(-12) M.Leukocytes, incubated with leukocyte lysates, were sampled at various times and assayed for free histamine released into the incubation mixture supernates, and for bound histamine associated with the leukocyte buttons after centrifugation. Theophylline, prostaglandin E(1) and dibutyryl cyclic AMP not only blocked histamine release, but also caused a progressive decrease in free histamine when added at any time up to 30 min after initiation of the release reaction. As the free histamine decreased after addition of the inhibitors, there was a corresponding increase in the bound histamine, suggesting that previously released histamine was reabsorbed by the leukocytes after exposure to cyclic AMP-active agents. Continued incubation of leukocytes in their own histamine after completion of the release reaction also resulted in reabsorption of the previously released histamine. Previous studies have indicated that cyclic AMP inhibits leukocyte histamine release. The results of the present studies suggest that cyclic AMP modulates histamine release induced by human leukocyte lysates by stimulating reabsorption of histamine from the extracellular environment. These studies also suggest that previously released extracellular histamine may stimulate its own reabsorption by increasing the intracellular level of cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4124206      PMCID: PMC302463          DOI: 10.1172/JCI107365

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3',5'-adenosine monophosphate in human leukocytes.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

2.  Inhibition of the anaphylactic mechanism by sympathomimetic amines.

Authors:  E S Assem; H O Schild
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

3.  The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.

Authors:  L M Lichtenstein; R DeBernardo
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

Review 4.  The related roles of histamine, serotonin and bradykinin in the pathogenesis of inflammation.

Authors:  R L Miller; K L Melmon
Journal:  Ser Haematol       Date:  1970

5.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Mediators of histamine release from human platelets, lymphocytes, and granulocytes.

Authors:  M T Kelly; R R Martin; A White
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

7.  Histamine release in vitro: inhibition by catecholamines and methylxanthines.

Authors:  L M Lichtenstein; S Margolis
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

8.  Histamine release in the dog after leukocyte lysate injection.

Authors:  M T Kelly; R E Brashear; R R Martin; A White
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

9.  Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity.

Authors:  H R Bourne; R I Lehrer; M J Cline; K L Melmon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

10.  Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release.

Authors:  H R Bourne; K L Melmon; L M Lichtenstein
Journal:  Science       Date:  1971-08-20       Impact factor: 47.728

View more
  5 in total

1.  Accumulation of histamine and cyclic nucleotides in lung tissue during chronic hypobaric hypoxia.

Authors:  N Völkel; E Kaukel; J Trautmann
Journal:  Lung       Date:  1978       Impact factor: 2.584

2.  Histamine-an important mediator for the Euler-Liljestrand mechanism?

Authors:  N Völkel; W Duschek; E Kaukel; W Beier; S Siemssen; V Sill
Journal:  Pneumonologie       Date:  1975-09-26

3.  An inhibitor of histamine release from human leukocytes.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

4.  Effect of purine nucleotides and other compounds on the uptake of histamine and histidine.

Authors:  E S Assem
Journal:  Agents Actions       Date:  1982-04

Review 5.  Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.

Authors:  P G Quie; K L Cates
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.